Abstract
Negative pressure wound therapy (NPWT) is frequently employed in the treatment of complex wounds. A variety of wound chemotherapeutic agents such as insulin, which acts as a growth factor, may prove helpful in treatment as well. We present a case report in which insulin was used as a chemotherapeutic agent in continuous-instillation NPWT. To our knowledge, this is the first report in the literature describing this method of delivery.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 820-824 |
| Number of pages | 5 |
| Journal | Journal of Diabetes Science and Technology |
| Volume | 4 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2010 |
Keywords
- Diabetic foot ulcers
- Insulin
- Negative pressure wound therapy
- Wound chemotherapy
ASJC Scopus subject areas
- Internal Medicine
- Bioengineering
- Endocrinology, Diabetes and Metabolism
- Biomedical Engineering
Fingerprint
Dive into the research topics of 'Novel use of insulin in continuous-instillation negative pressure wound therapy as "wound chemotherapy"'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS